KIMBERLY HILL: Open Payments
NPI 1710303631 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 55 payments from 11 companies in 2025. Trend: 2023 $1,116 · 2024 $1,293 · 2025 $1,680
Food & beverage: $1,680
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $392 |
| ViiV Healthcare Company | 15 | $356 |
| Gilead Sciences, Inc. | 6 | $336 |
| Axsome Therapeutics, Inc. | 5 | $173 |
| Theratechnologies Inc. | 5 | $127 |
| Merck Sharp & Dohme LLC | 2 | $76 |
| ABBVIE INC. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Novo Nordisk Inc | 1 | $18 |
Products named: SPRAVATO, Auvelity, APRETUDE, EGRIFTA, DOVATO, Biktarvy, CABENUVA, PIFELTRO.
Industry payments across AR — which companies pay providers there.
